DIMERIX INVESTOR CALL & PRESENTATION
Dimerix
A biopharmaceutical company developing innovative new therapies in areas with unmet medical needs, with a core focus
on inflammatory disease treatments such as kidney and respiratory diseases.
Advancing three Phase 3 opportunities
Well positioned to deliver against strategic plan
Dimerix HQ
425 Smith St, Fitzroy 3065
Victoria, Australia
T. 1300 813 321
E. [email protected]
ESG Statement
Dimerix is committed to integrating Environmental, Social and Governance (ESG) considerations across the development cycle of its programs, processes and decision making. The Dimerix commitment
to improve its ESG performance demonstrate a strong, well-informed management attitude and a values led culture that is both alert and responsive to the challenges and opportunities of doing
business responsibly and sustainably.View entire presentation